AtriCure Analyst Price Targets - Benzinga

AtriCure Inc

ATRCNASDAQ

Trade with Public

Trade with Public

$58.10

-1.02-1.73%

가까이에: Sep 18, 5:00 PM EST

$58.10

-0.00250%

시간외: Sep 18, 4:29 PM EST

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 옵션 주식 보고서

AtriCure Analyst Price Targets

Wall Street analyst price targets and consensus rating for AtriCure (ATRC).

Price Target Range — 13 Quarters

Analyst Consensus — 10 Analysts

3S.Buy

7Buy

Consensus RatingBuy# Analysts10Avg. Consensus PT$54Upside to Avg. PT-7.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2026	Needham	Mike Matson	PT Raise	Buy	$45→$64
Aug 27, 2026	Piper Sandler	Matt O'Brien	PT Raise	Overweight	$50→$60
Aug 24, 2026	BTIG	Marie Thibault	PT Raise	Buy	$45→$55
Jul 28, 2026	UBS	Priya Sachdeva	PT Cut	Buy	$55→$50
May 6, 2026	Canaccord Genuity	William Plovanic	PT Raise	Buy	$53→$55
Feb 18, 2026	Canaccord Genuity	William Plovanic	PT Cut	Buy	$64→$53
Feb 18, 2026	UBS	Danielle Antalffy	PT Cut	Buy	$60→$55
Feb 18, 2026	Citizens	Daniel Stauder	PT Cut	Market Outperform	$60→$52
Feb 18, 2026	Oppenheimer	Suraj Kalia	Downgrade	Outperform→Perform	—
Feb 18, 2026	BTIG	Marie Thibault	Maintained	Buy	$54
Feb 12, 2026	Needham	Mike Matson	Maintained	Buy	$45
Dec 16, 2025	JP Morgan	Lilia-Celine Lozada	PT Raise	Overweight	$42→$48
Oct 30, 2025	Canaccord Genuity	William Plovanic	PT Raise	Buy	$53→$64
Jul 30, 2025	Needham	Mike Matson	PT Raise	Buy	$44→$45
Apr 30, 2025	BTIG	Marie Thibault	PT Cut	Buy	$58→$52
Apr 30, 2025	UBS	Danielle Antalffy	PT Cut	Buy	$60→$58
Apr 30, 2025	JMP Securities	Daniel Stauder	Maintained	Market Outperform	$60
Apr 30, 2025	Needham	Mike Matson	PT Cut	Buy	$51→$44
Apr 2, 2025	Citizens Capital Markets	Daniel Stauder	Maintained	Market Outperform	$60
Mar 28, 2025	Canaccord Genuity	William Plovanic	PT Cut	Buy	$66→$52

More with Benzinga EdgeGet Access

Analyst Ratings News

Salesforce To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Cantor Fitzgerald raised

Avi Kapoor

PRO
Needham Maintains Buy on AtriCure, Raises Price Target to $64

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $45 to $64.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on AtriCure, Raises Price Target to $60

Piper Sandler analyst Matt O'Brien maintains AtriCure (NASDAQ:ATRC) with a Overweight and raises the price target from $50 to $60.

Benzinga Newsdesk

Analog Devices To Rally Around 81%? Here Are 10 Top Analyst Forecasts For Monday

Top analysts change outlook on top names. See all rating changes, including upgrades/downgrades, on analyst ratings page. Follow other analysts.

Avi Kapoor

PRO
BTIG Maintains Buy on AtriCure, Raises Price Target to $55

BTIG analyst Marie Thibault maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $45 to $55.

Benzinga Newsdesk

PRO
UBS Maintains Buy on AtriCure, Lowers Price Target to $50

UBS analyst Priya Sachdeva maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $55 to $50.

Benzinga Newsdesk